Yellow Fluorescent Protein Activators (YFP Activators) belong to a specialized chemical class that interacts specifically with Yellow Fluorescent Proteins (YFP) to enhance or induce their fluorescence. These activators play a crucial role in molecular and cellular biology, facilitating the visualization of proteins, their interactions, and their functions within biological systems. YFPs are variants of the Green Fluorescent Protein (GFP), originally found in the jellyfish Aequorea victoria, and have been engineered to emit fluorescence in the yellow region of the visible spectrum when activated. YFP Activators typically interact with the chromophore within the YFP, a component responsible for its fluorescent properties. By binding to or modifying the chromophore's structure or surrounding environment, these activators can increase the efficiency of fluorescence emission, shift the emission wavelength, or stabilize the fluorescent state of the protein.
The design and application of YFP Activators require an in-depth understanding of the protein's structure and the mechanisms underlying its fluorescence. These activators can be small organic molecules, ions, or other proteins engineered to interact specifically with YFPs. The interaction can lead to changes in the protein's conformation, affecting the chromophore's electronic structure and thus modulating its fluorescence properties. This modulation is highly valuable in research settings, as it enables scientists to track and analyze the behavior of specific proteins in live cells or in vitro, contributing to a deeper understanding of cellular processes, protein dynamics, and molecular interactions. The ability to control and modulate fluorescence in YFPs through the use of activators has been instrumental in the advancement of fluorescence microscopy and other imaging techniques, facilitating high-resolution visualization and real-time monitoring of biological phenomena.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IPTG, Dioxane-Free | 367-93-1 | sc-202185 sc-202185A sc-202185B sc-202185C sc-202185D sc-202185E sc-202185F | 1 g 5 g 100 g 500 g 1 kg 10 kg 25 kg | $50.00 $115.00 $500.00 $1750.00 $2000.00 $16320.00 $32130.00 | 27 | |
IPTG is a lactose analog that can induce the expression of genes under the control of the lac operon, potentially leading to YFP production if the YFP gene is linked to this operon. | ||||||
Anhydrotetracycline | 1665-56-1 | sc-481048 | 2.5 mg | $326.00 | ||
Anhydrotetracycline, a tetracycline analog, can be used to control the Tet-on/Tet-off gene expression system, potentially leading to YFP expression if placed under this system. | ||||||
Doxycycline-d6 | 564-25-0 unlabeled | sc-218274 | 1 mg | $16500.00 | ||
Similar to tetracycline, doxycycline can modulate gene expression in Tet-on/Tet-off systems, which could drive YFP expression when applied. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
17-β-Estradiol can bind to estrogen receptors, possibly leading to the activation of specific estrogen-responsive promoters and potentially inducing YFP expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone interacts with glucocorticoid receptors, and can activate promoters containing glucocorticoid response elements, potentially inducing YFP expression. | ||||||
Mifepristone | 84371-65-3 | sc-203134 | 100 mg | $60.00 | 17 | |
Mifepristone can modulate the activity of progesterone receptors and may be used to control gene expression systems, potentially leading to YFP expression. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $252.00 $495.00 | 9 | |
Atorvastatin inhibits HMG-CoA reductase, potentially leading to alterations in gene expression profiles, including the induction of YFP expression under certain conditions. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin can activate specific signaling pathways, potentially leading to the induction of YFP expression when YFP is placed under the control of elements responsive to these pathways. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor that can alter chromatin structure, potentially leading to increased accessibility of the YFP gene and its subsequent expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Decitabine is a DNA methyltransferase inhibitor, potentially leading to demethylation of the YFP gene promoter and enhancing its expression. | ||||||